The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to cell and gene therapy manufacturing market will
help companies and investors design strategic landscapes.
cell therapy was the
largest segment with a revenue share of
59.88% in
2022.
Horizon Databook has segmented the Global cell and gene therapy manufacturing market based on gene therapy, cell therapy covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Cell And Gene Therapy Manufacturing Therapy Type Outlook (Revenue, USD Million, 2018-2030)
- Gene Therapy
- Cell Therapy
- Stem Cell Therapy
- Non Stem Cell Therapy
- Global Cell And Gene Therapy Manufacturing Scale Outlook (Revenue, USD Million, 2018-2030)
- Pre-commercial/ R&D Scale
- Commercial Scale
- Global Cell And Gene Therapy Manufacturing Mode Outlook (Revenue, USD Million, 2018-2030)
- Contract manufacturing
- In house manufacturing
- Global Cell And Gene Therapy Manufacturing Workflow Outlook (Revenue, USD Million, 2018-2030)
- Cell Processing
- Cell Banking
- Process Development
- Fill & Finish Operations
- Analytical & Quality Testing
- Raw Material Testing
- Vector Production
- Others
- Global Cell And Gene Therapy Manufacturing Indication Outlook (Revenue, USD Million, 2018-2030)
- Acute Lymphoblastic Leukemia (ALL)
- Inherited Retinal Disease
- Malignancies
- Musculoskeletal therapies
- Autoimmune disorders
- Dermatology
- Large B-Cell Lymphoma
- Spinal Muscular Atrophy (SMA)
- Others
Reasons to
subscribe to Global cell and gene therapy manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global cell and gene therapy manufacturing market databook
-
Our clientele includes a mix of cell and gene therapy manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global cell and gene therapy manufacturing market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global cell and gene therapy manufacturing market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.